Cognitive dysfunction and cancer: which consequences in terms of disease management?, Psycho-Oncology, vol.48, issue.16 suppl, pp.1251-1258, 2011. ,
DOI : 10.1002/pon.1903
Brain vulnerability to chemotherapy toxicities, Psycho-Oncology, vol.153, issue.11, pp.1141-1148, 2012. ,
DOI : 10.1002/pon.3196
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788849
Opening up the Window into ???Chemobrain???: A Neuroimaging Review, Sensors, vol.13, issue.3, pp.3169-3203, 2013. ,
DOI : 10.3390/s130303169
Candidate mechanisms for chemotherapy-induced cognitive changes, Nature Reviews Cancer, vol.85, issue.3, pp.192-201, 2007. ,
DOI : 10.1038/nrc2073
Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study, Journal of the American Geriatrics Society, vol.11, issue.6, pp.925-931, 2006. ,
DOI : 10.1111/j.1532-5415.2006.00732.x
Population-Based Norms for the Mini-Mental State Examination by Age and Educational Level, JAMA: The Journal of the American Medical Association, vol.269, issue.18, pp.2386-2391, 1993. ,
DOI : 10.1001/jama.1993.03500180078038
[French standardization of the "Mini Mental State, MMS) GRECO version, pp.209-236, 2003. ,
???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-198, 1975. ,
DOI : 10.1016/0022-3956(75)90026-6
Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, Acta Neurol Belg, vol.90, pp.207-217, 1990. ,
Manual of copy and memory reproduction test of complexe geometric figures]. Paris : Éditions Centre de psychologie appliquée, 1959. ,
VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGE, Perceptual and Motor Skills, vol.19, issue.3, pp.271-276, 1958. ,
DOI : 10.2466/pms.1958.8.3.271
Wechsler Adult Intelligence Scale-III. San Antonio: The Psychological Corporation, 1997. ,
French version of the Functional Assessment of Cancer Therapy???Cognitive Function (FACT-Cog) version 3, Supportive Care in Cancer, vol.22, issue.12, pp.3297-3305, 2012. ,
DOI : 10.1007/s00520-012-1439-2
Measuring Patient Self-Reported Cognitive Function: Development of the Functional Assessment of Cancer Therapy?Cognitive Function Instrument, J Support Oncol, vol.7, pp.32-39, 2009. ,
Assessment of Depression: The Depression Inventory, Mod Probl Pharmacopsychiatry, vol.7, pp.151-169, 1974. ,
DOI : 10.1159/000395074
Manual for the State-Trait Anxiety Inventory (STAI), 1983. ,
Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system, Journal of Pain and Symptom Management, vol.13, issue.2, pp.63-74, 1997. ,
DOI : 10.1016/S0885-3924(96)00274-6
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument., Journal of Clinical Oncology, vol.15, issue.3, pp.974-986, 1997. ,
DOI : 10.1200/JCO.1997.15.3.974
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure., Journal of Clinical Oncology, vol.11, issue.3, pp.570-579, 1993. ,
DOI : 10.1200/JCO.1993.11.3.570
[Development and contribution to the validation of a brief French version of the Yesavage Geriatric Depression Scale], Encephale, vol.23, pp.91-99, 1997. ,
ASSESSMENT OF OLDER PEOPLE, Nursing Research, vol.19, issue.3, pp.179-186, 1969. ,
DOI : 10.1097/00006199-197005000-00029
Progress in Development of the Index of ADL, The Gerontologist, vol.10, issue.1 Part 1, pp.20-30, 1970. ,
DOI : 10.1093/geront/10.1_Part_1.20
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation, Journal of Chronic Diseases, vol.40, issue.5, pp.373-383, 1987. ,
DOI : 10.1016/0021-9681(87)90171-8
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, The Lancet Oncology, vol.12, issue.7, pp.703-708, 2011. ,
DOI : 10.1016/S1470-2045(10)70294-1
Cognitive impairment in men with testicular cancer prior to adjuvant therapy, Cancer, vol.5, issue.pt 7, pp.190-196, 2011. ,
DOI : 10.1002/cncr.25298
An empirical approach to determining criteria for abnormality in test batteries with multiple measures., Neuropsychology, vol.10, issue.1, pp.120-124, 1996. ,
DOI : 10.1037/0894-4105.10.1.120
Fatigue during breast radiotherapy and its relationship to biological factors, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.1, pp.160-167, 2004. ,
DOI : 10.1016/j.ijrobp.2003.10.008
General Population and Cancer Patient Norms for the Functional Assessment of Cancer Therapy-General (FACT-G), Evaluation & the Health Professions, vol.28, issue.2, pp.192-211, 2005. ,
DOI : 10.1177/0163278705275341
Chemobrain Is Real but May Need New Name, JNCI Journal of the National Cancer Institute, vol.100, issue.3, pp.162-165, 2008. ,
DOI : 10.1093/jnci/djn007
URL : http://jnci.oxfordjournals.org/cgi/content/short/100/3/162
Renaming ???Chemobrain???, Cancer Investigation, vol.18, issue.14, pp.373-377, 2007. ,
DOI : 10.1002/pon.709
Cancer- and Cancer Treatment???Associated Cognitive Change: An Update on the State of the Science, Journal of Clinical Oncology, vol.30, issue.30, pp.3675-3686, 2012. ,
DOI : 10.1200/JCO.2012.43.0116
Subjective cognitive dysfunction in breast cancer patients: a systematic review, Psycho-Oncology, vol.129, issue.3, pp.1127-1138, 2010. ,
DOI : 10.1002/pon.1673
Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance, JNCI Journal of the National Cancer Institute, vol.105, issue.11, pp.791-801, 2013. ,
DOI : 10.1093/jnci/djt073